Loading…
Eton Pharmaceuticals, Inc. is projected to rise to $40.73 by 2027, a +26% move from its current price of $32.40. ETON is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $31.32 | $32.39 | $33.50 | -0.02% |
| May 30 | $30.88 | $32.38 | $33.97 | -0.05% |
| May 31 | $30.54 | $32.38 | $34.32 | -0.07% |
| Jun 1 | $30.26 | $32.37 | $34.63 | -0.09% |
| Jun 2 | $30.01 | $32.36 | $34.90 | -0.12% |
| Jun 3 | $29.79 | $32.35 | $35.14 | -0.14% |
| Jun 4 | $29.59 | $32.35 | $35.36 | -0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.59 | $32.35 | $35.36 | -0.16% |
| Week 2 | $28.47 | $32.29 | $36.64 | -0.33% |
| Week 3 | $27.63 | $32.24 | $37.63 | -0.49% |
| Week 4 | $26.93 | $32.19 | $38.47 | -0.65% |
| Week 5 | $26.33 | $32.14 | $39.23 | -0.81% |
| Week 6 | $25.79 | $32.08 | $39.92 | -0.97% |
| Week 7 | $25.30 | $32.03 | $40.56 | -1.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis.
Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Eton Pharmaceuticals, Inc. trades with a current price of $32.59 and a market cap of $892.72M. Its rank is 2619. The near-term and longer-term outlook is bullish, with a multi-year forecast showing rising averages and higher ROI over time.
For 2026 the forecast shows a min of $14.35, an avg of $32.59, and a max of $46.46 with ROI 0, while the 2030–2050 period projects substantially higher averages and ROI levels.
A major floor 55.7% below — a decisive break under it would weaken the trend.
The nearest floor, 29.1% below — buyers have tended to step in here.
The nearest ceiling, 8.0% above — a clean break opens room to run.
A major ceiling 30.1% above — clearing it would confirm fresh momentum.
Key ETON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ETON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $33.15 | Sell | $32.46 | Sell |
| MA 10 | $32.22 | Buy | $32.00 | Buy |
| MA 20 | $30.48 | Buy | $30.52 | Buy |
| MA 50 | $26.62 | Buy | $26.97 | Buy |
| MA 100 | $21.52 | Buy | $23.64 | Buy |
| MA 200 | $19.63 | Buy | $20.53 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.72 | Neutral |
| Stoch RSI (14) | 17.34 | Buy |
| CCI (20) | 68.70 | Neutral |
| Williams %R (14) | -48.60 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 9.27 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 51.40 | Neutral |
| TRIX (15) | 1.10 | Buy |
| Awesome (5,34) | 4.95 | Buy |
| Ultimate (7,14,28) | 60.78 | Neutral |
| Momentum (10) | 2.69 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 32.72 | Sell |
| ADX (14) | 31.65 | Buy |
| ATR (14) | 1.02 | Info |
The 30-day technical picture is bullish overall. RSI14 is 60, with the 50-day simple moving average at $26.11 and the 200-day simple moving average at $19.47. Key technical levels place support at $22.97 and resistance at $35.00, with the latest 30-day range spanning from a low of $26.06 to a high of $40.76.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $14.35 | $32.40 | $46.10 | 0% | Neutral | |
| $31.57 | $40.73 | $56.08 | +26% | Bullish | |
| $43.32 | $57.85 | $83.12 | +79% | Bullish | |
| $52.67 | $72.40 | $107.57 | +123% | Bullish | |
| $59.79 | $84.35 | $128.91 | +160% | Bullish | |
| $68.48 | $98.93 | $154.96 | +205% | Bullish | |
| $67.97 | $100.40 | $160.77 | +210% | Bullish | |
| $72.88 | $109.96 | $179.62 | +239% | Bullish | |
| $91.03 | $140.12 | $233.13 | +332% | Bullish | |
| $113.58 | $178.25 | $301.63 | +450% | Bullish | |
| $149.52 | $256.54 | $465.97 | +692% | Bullish | |
| $299.78 | $602.89 | $1,213.03 | +17.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $14.35 | $32.40 | $38.03 | +0.00% |
| June 2026 | $26.50 | $31.28 | $37.91 | -3.47% |
| July 2026 | $26.59 | $31.72 | $39.09 | +1.42% |
| August 2026 | $27.15 | $32.65 | $40.75 | +2.94% |
| September 2026 | $26.45 | $32.02 | $40.37 | -1.93% |
| October 2026 | $26.28 | $32.01 | $40.74 | -0.02% |
| November 2026 | $27.87 | $34.14 | $43.80 | +6.64% |
| December 2026 | $28.96 | $35.66 | $46.10 | +4.45% |
Click any year to see its month-by-month ETON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ETON price prediction for 2026 points to an average of $32.40 (low $14.35, high $46.10) — a potential gain of 0% on today's $32.40. A consolidation phase looks the most probable path here.
In 2027, ETON is projected to trade between $31.57 and $56.08, averaging $40.73 — a potential gain of +26% from today's $32.40. That is up +26% on the projected 2026 average. Momentum favours further upside here.
Eton Pharmaceuticals, Inc.'s 2028 outlook centres on $57.85, within a $43.32 to $83.12 range. That is up +42% on the projected 2027 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ETON could reach as high as $107.57, with a base case around $72.40 and support toward $52.67 — roughly +123% from $32.40. Momentum favours further upside here.
Expect ETON to range from $59.79 to $128.91 through 2030. The $84.35 average target implies a +160% move from current prices. That is up +17% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ETON price prediction for 2031 points to an average of $98.93 (low $68.48, high $154.96) — a potential gain of +205% on today's $32.40. Momentum favours further upside here.
In 2032, ETON is projected to trade between $67.97 and $160.77, averaging $100.40 — a potential gain of +210% from today's $32.40. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Eton Pharmaceuticals, Inc.'s 2033 outlook centres on $109.96, within a $72.88 to $179.62 range. That is up +10% on the projected 2032 average. That marks a +239% change versus current levels. Momentum favours further upside here.
By 2034, ETON could reach as high as $233.13, with a base case around $140.12 and support toward $91.03 — roughly +332% from $32.40. Buyers look set to stay in control over this stretch.
Expect ETON to range from $113.58 to $301.63 through 2035. The $178.25 average target implies a +450% move from current prices. That is up +27% on the projected 2034 average. Momentum favours further upside here.
The ETON price prediction for 2040 points to an average of $256.54 (low $149.52, high $465.97) — a potential gain of +692% on today's $32.40. Buyers look set to stay in control over this stretch.
In 2050, ETON is projected to trade between $299.78 and $1,213.03, averaging $602.89 — a potential gain of +17.6x from today's $32.40. That is up +135% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ETON today (≈ 30.864198 ETON) could be worth
$18,607.58
+$17,607.58 (+1761%) by 2050 · US Dollar
Based on the average projected ETON price of $602.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ETONwould be worth at today's price.
$1,000 invested in ETON on May 27, 2025 (≈ 49.900197 ETON) would be worth
$1,616.77
+$616.77 (+61.7%) today · 1.62× · US Dollar
Based on a ETON entry price of $20.04 vs. today's $32.4.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $34.45 | $940.49 | -6.0% |
| 1 month ago | $23.45 | $1,381.66 | +38.2% |
| 3 months ago | $17.25 | $1,878.26 | +87.8% |
| 6 months ago | $16.15 | $2,006.19 | +100.6% |
| 1 year ago | $20.04 | $1,616.77 | +61.7% |
| All time (5.0y) ago | $6.21 | $5,217.39 | +421.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ETON forecast.
Our base-case forecast reaches $65.00 around 2029.
Implied market cap at $65.00: $1.78B
The multi-year forecast shows a persistent bullish tilt, with rising average prices and expanding ROI across the years. By 2030 the avg is $84.56 and ROI is 159.5, supported by a bullish sentiment. The trajectory continues to 2040 with an avg of $256.71 and ROI of 687.7, and reaches 2050 with an avg of $597.99 and ROI of 1734.9, indicating strong long-term upside but with inherent uncertainty as these figures are estimates.
Tap a question to reveal the answer.
2026 min $14.35, avg $32.59, max $46.46; ROI 0; sentiment NEUTRAL.
The forecast shows bullish sentiment from 2027 onward, with 2027 avg $40.83, 2030 avg $84.56 (ROI 159.5), 2040 avg $256.71 (ROI 687.7), and 2050 avg $597.99 (ROI 1734.9). These are estimates and not guarantees.
Yes. The 2033 forecast shows avg $109.71, and 2031 max $156.58 indicates potential above $100 at times in the forecast window.
Current price is $32.59 and market cap is $892.72M; rank 2619.
30-day range low $26.06, high $40.76; RSI14 60; SMA50 $26.11; SMA200 $19.47; support $22.97; resistance $35.00; annualized volatility 60%.
Eton Pharmaceuticals, Inc. Community Discussion
0Share your Eton Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.